Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study.

× No keyword cloud information.

4 in total

1. In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).

Authors: D W Fry; T J Boritzki; J A Besserer; R C Jackson
Journal: Biochem Pharmacol Date: 1985-10-01 Impact factor: 5.858

2. 5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation.

Authors: H D Showalter; J L Johnson; L M Werbel; W R Leopold; R C Jackson; E F Elslager
Journal: J Med Chem Date: 1984-03 Impact factor: 7.446

3. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.

Authors: W R Leopold; J M Nelson; J Plowman; R C Jackson
Journal: Cancer Res Date: 1985-11 Impact factor: 12.701

4. Reporting results of cancer treatment.

Authors: A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal: Cancer Date: 1981-01-01 Impact factor: 6.860

4 in total

2 in total

1. Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Authors: M M Zalupski; J Benedetti; S P Balcerzak; L F Hutchins; R J Belt; A Hantel; J W Goodwin
Journal: Invest New Drugs Date: 1993-11 Impact factor: 3.850

2. Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.

Authors: P M Ravdin; S Green; J H Doroshow; S Martino
Journal: Invest New Drugs Date: 1994 Impact factor: 3.850

2 in total